Alnylam Pharmaceuticals Aktie

155,35EUR
+3,25EUR
+2,14%
183,01USD
+1,20USD
+0,66%
Hier für 0 Euro handeln mit
Werbung
mehr Daten anzeigen

Alnylam Pharmaceuticals Aktie Analyse

01.10.18 Alnylam Pharmaceuticals Overweight Cantor Fitzgerald
13.08.18 Alnylam Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
07.08.18 Alnylam Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
05.07.18 Alnylam Pharmaceuticals Buy Chardan Capital Markets
04.05.18 Alnylam Pharmaceuticals Hold Stifel, Nicolaus & Co., Inc.
16.02.18 Alnylam Pharmaceuticals Buy B. Riley FBR, Inc.
08.01.18 Alnylam Pharmaceuticals Buy B. Riley FBR, Inc.
08.11.17 Alnylam Pharmaceuticals overweight Barclays Capital
Werbung
08.11.17 Alnylam Pharmaceuticals Buy B. Riley FBR, Inc.
03.11.17 Alnylam Pharmaceuticals Buy Needham & Company, LLC
02.11.17 Alnylam Pharmaceuticals Buy B. Riley FBR, Inc.
30.10.17 Alnylam Pharmaceuticals Buy FBR & Co.
21.09.17 Alnylam Pharmaceuticals Buy Needham & Company, LLC
15.05.17 Alnylam Pharmaceuticals Buy Chardan Capital Markets
21.04.17 Alnylam Pharmaceuticals Outperform BMO Capital Markets
30.03.17 Alnylam Pharmaceuticals Neutral UBS AG
09.02.17 Alnylam Pharmaceuticals Buy Needham & Company, LLC
19.12.16 Alnylam Pharmaceuticals Buy Chardan Capital Markets
30.11.16 Alnylam Pharmaceuticals Buy Chardan Capital Markets
16.11.16 Alnylam Pharmaceuticals Buy Needham & Company, LLC
06.10.16 Alnylam Pharmaceuticals Outperform FBR & Co.
06.10.16 Alnylam Pharmaceuticals Hold Stifel, Nicolaus & Co., Inc.
06.10.16 Alnylam Pharmaceuticals Buy Needham & Company, LLC
06.10.16 Alnylam Pharmaceuticals Buy Chardan Capital Markets
26.05.16 Alnylam Pharmaceuticals Buy Chardan Capital Markets
05.04.16 Alnylam Pharmaceuticals Buy Chardan Capital Markets
11.08.15 Alnylam Pharmaceuticals Outperform FBR Capital
22.04.15 Alnylam Pharmaceuticals Buy Needham & Company, LLC
04.03.15 Alnylam Pharmaceuticals overweight Barclays Capital
17.11.14 Alnylam Pharmaceuticals Buy Needham & Company, LLC
24.11.09 Alnylam Pharmaceuticals hold ROTH Capital Partners, LLC
13.11.09 Alnylam Pharmaceuticals outperform Rodman & Renshaw, LLC
10.06.09 Alnylam Pharmaceuticals buy Jefferies & Company Inc.
10.06.09 Alnylam Pharmaceuticals buy ROTH Capital Partners, LLC
26.02.09 Alnylam Pharmaceuticals hold Needham & Company, LLC
25.02.09 Alnylam Pharmaceuticals hold Needham & Company, LLC
21.01.09 Alnylam Pharmaceuticals market outperform Rodman & Renshaw, LLC
11.12.08 Alnylam Pharmaceuticals Focus Money
15.09.08 Alnylam Pharmaceuticals market weight Thomas Weisel Partners LLC
21.08.08 Alnylam Pharmaceuticals Focus Money
20.08.08 Alnylam Pharmaceuticals underperform Leerink Swann LLC
03.03.08 Alnylam Pharmaceuticals underperform Needham & Company, LLC
19.02.08 Alnylam Pharmaceuticals Biotech-Report
24.10.07 Alnylam Pharmaceuticals market outperform Rodman & Renshaw
10.10.07 Alnylam Pharmaceuticals market perform Piper Jaffray & Co.
14.08.07 Alnylam Pharmaceuticals hold Needham & Company, LLC
10.07.07 Alnylam Pharmaceuticals market outperform Rodman & Renshaw
10.07.07 Alnylam Pharmaceuticals above average Caris & Company
12.05.06 Alnylam Pharmaceuticals Above Average Caris & Company
13.02.06 Alnylam Pharmaceuticals Buy Needham & Co
Seite: 1 | 2

Analysensuche

GO
Werbung

Aktuelle News zu

finanzen.net Brokerage
finanzen.net Brokerage

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln